indapamide has been researched along with Brain Vascular Disorders in 13 studies
Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.
Excerpt | Relevance | Reference |
---|---|---|
"The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) showed that blood pressure lowering reduced stroke risk in patients with a history of cerebrovascular events." | 9.11 | Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. ( Anderson, C; Bousser, MG; Chalmers, J; Chapman, N; Colman, S; Davis, S; Donnan, G; Huxley, R; MacMahon, S; Neal, B; Warlow, C; Woodward, M, 2004) |
"The primary aim of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) is to determine the effects of a long-term angiotensin converting enzyme (ACE)-inhibitor-based blood-pressure-lowering regimen on the risk of stroke among patients with a history of stroke or transient ischaemic attack (TIA)." | 9.09 | PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee. ( , 1999) |
"The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) showed that blood pressure lowering reduced stroke risk in patients with a history of cerebrovascular events." | 5.11 | Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. ( Anderson, C; Bousser, MG; Chalmers, J; Chapman, N; Colman, S; Davis, S; Donnan, G; Huxley, R; MacMahon, S; Neal, B; Warlow, C; Woodward, M, 2004) |
"Among individuals with cerebrovascular disease, a perindopril-based blood pressure-lowering regimen not only reduced the risk of stroke and major vascular events but also substantially reduced the risks of associated long-term disability and dependency." | 5.10 | Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial. ( Anderson, C; Chalmers, J; Chapman, N; Davis, S; Fransen, M; MacMahon, S; Neal, B; Sega, R; Terent, A; Tzourio, C; Woodward, M, 2003) |
"The primary aim of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) is to determine the effects of a long-term angiotensin converting enzyme (ACE)-inhibitor-based blood-pressure-lowering regimen on the risk of stroke among patients with a history of stroke or transient ischaemic attack (TIA)." | 5.09 | PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee. ( , 1999) |
"5 mg SR formulation of indapamide has an improved antihypertensive efficacy : safety ratio, which is in accordance with international recommendations for the use of low-dose antihypertensive drugs and diuretics in first-line therapy of hypertension." | 5.08 | Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group. ( Ambrosioni, E; de Cordoüe, A; Degaute, JP; Guez, D; MacMahon, M; Malin, PL; Pujol, DR; Safar, M, 1998) |
"Hyperlipidemia is a widely acknowledged side effect of thiazide diuretic therapy, but it is often dismissed as a short-term effect of high-dose therapy." | 2.40 | Hyperlipidemia of diuretic therapy. ( Ames, R, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (69.23) | 18.2507 |
2000's | 3 (23.08) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afanas'ev, IuI | 1 |
Storozhenko, SIu | 1 |
Grigorova, SIu | 1 |
Tzourio, C | 2 |
Anderson, C | 3 |
Chapman, N | 3 |
Woodward, M | 3 |
Neal, B | 3 |
MacMahon, S | 3 |
Chalmers, J | 3 |
Fransen, M | 1 |
Davis, S | 2 |
Sega, R | 1 |
Terent, A | 1 |
Huxley, R | 1 |
Bousser, MG | 1 |
Colman, S | 1 |
Donnan, G | 1 |
Warlow, C | 1 |
Contard, F | 1 |
Sabri, A | 1 |
Glukhova, M | 1 |
Sartore, S | 1 |
Marotte, F | 1 |
Pomies, JP | 1 |
Schiavi, P | 1 |
Guez, D | 2 |
Samuel, JL | 1 |
Rappaport, L | 1 |
Levy, BI | 1 |
Poitevin, P | 1 |
Duriez, M | 1 |
Guez, DC | 1 |
Schiavi, PD | 1 |
Safar, ME | 1 |
Biagini, G | 2 |
Zoli, M | 1 |
Torri, C | 1 |
Boschi, S | 1 |
Vantaggiato, G | 1 |
Ballestri, M | 1 |
Baraldi, A | 1 |
Agnati, LF | 1 |
Ames, R | 1 |
Razzetti, R | 1 |
Bongrani, S | 1 |
Oberto, G | 1 |
Ferrari, R | 1 |
Ambrosioni, E | 1 |
Safar, M | 1 |
Degaute, JP | 1 |
Malin, PL | 1 |
MacMahon, M | 1 |
Pujol, DR | 1 |
de Cordoüe, A | 1 |
1 review available for indapamide and Brain Vascular Disorders
Article | Year |
---|---|
Hyperlipidemia of diuretic therapy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cere | 1998 |
7 trials available for indapamide and Brain Vascular Disorders
Article | Year |
---|---|
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cerebrovasc | 2003 |
Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.
Topics: Activities of Daily Living; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood | 2003 |
Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Brain Ische | 2004 |
Post-stroke antihypertensive treatment study. A preliminary result.
Topics: Aged; Antihypertensive Agents; Cerebrovascular Disorders; China; Double-Blind Method; Female; Humans | 1995 |
PROGRESS: Perindopril pROtection aGainst REcurrent Stroke Study: status in March 1997. PROGRESS Management Committee.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cerebrovascular Disorders; Diuretics; Double-Blind M | 1998 |
Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group.
Topics: Adult; Aged; Angina Pectoris; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; De | 1998 |
PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cerebrovascular Disorders; Diuretics | 1999 |
5 other studies available for indapamide and Brain Vascular Disorders
Article | Year |
---|---|
[Potentialities of medicinal correction of cerebrovascular disturbances in patients with arterial hypertension].
Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Cerebrovascular Disorders; Drug Therapy, Combinatio | 2012 |
Arterial smooth muscle cell phenotype in stroke-prone spontaneously hypertensive rats.
Topics: Actins; Animals; Aorta, Thoracic; Cerebral Cortex; Cerebrovascular Disorders; Fibronectins; Hydrochl | 1993 |
Sodium, survival, and the mechanical properties of the carotid artery in stroke-prone hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Carotid Artery, Common; Cerebrovascular Disorders; Collagen; D | 1997 |
Protective effects of delapril, indapamide and their combination chronically administered to stroke-prone spontaneously hypertensive rats fed a high-sodium diet.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bl | 1997 |
Protective effects of delapril, indapamide and their combination on stroke occurrence and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cerebrovascular Disorders; Diuretics | 1998 |